InceptionR’s DexCom DXCM Stock Holding History

InceptionR’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,252	Closed	-$290K	–	699
2025 Q1	$290K	Sell	4,252 -4,281	-50%	-$349K	0.09%	386
2024 Q4	$664K	Buy	8,533 +1,324	+18%	+$98K	0.15%	274
2024 Q3	$483K	Buy	+7,209	New	+$592K	0.12%	325

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

InceptionR's DXCM Position: Q2 2025 in Review

InceptionR sold out of DexCom (DXCM) in Q2 2025, closing a stake of 4,252 shares — an estimated $290K sold.

InceptionR first reported a position in DXCM in Q3 2024 and held it in 3 quarters. The position peaked at $664K in Q4 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

InceptionR reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
InceptionR sold 4,252 DexCom shares in Q2 2025, an estimated $290K.
InceptionR first reported a position in DexCom in Q3 2024 and held it in 3 quarters.
InceptionR's DexCom position peaked at $664K in Q4 2024.
939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on InceptionR's 13F filing for Q2 2025, filed 12 Aug 2025.